[go: up one dir, main page]

AR084848A1 - Proceso para la purificacion de 6,6’-(3,3’-di-tert-butil-5,5’-dimetoxi-1,1’-bifenil-2,2’-diil)bis(oxi)]bis(dibenzo[d,f][1,3,2]dioxafosfepina) (biphephos) - Google Patents

Proceso para la purificacion de 6,6’-(3,3’-di-tert-butil-5,5’-dimetoxi-1,1’-bifenil-2,2’-diil)bis(oxi)]bis(dibenzo[d,f][1,3,2]dioxafosfepina) (biphephos)

Info

Publication number
AR084848A1
AR084848A1 ARP120100118A ARP120100118A AR084848A1 AR 084848 A1 AR084848 A1 AR 084848A1 AR P120100118 A ARP120100118 A AR P120100118A AR P120100118 A ARP120100118 A AR P120100118A AR 084848 A1 AR084848 A1 AR 084848A1
Authority
AR
Argentina
Prior art keywords
bis
biphephos
dioxaphosphepine
dibenzo
diyl
Prior art date
Application number
ARP120100118A
Other languages
English (en)
Inventor
Kreidler Burkard Dr
Dirk Fridag
Bernhard Schemmer
Bjoern Wechsler
Christiansen Andrea Dra
Neumann Doris Dra
Original Assignee
Evonik Oxeno Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Oxeno Gmbh filed Critical Evonik Oxeno Gmbh
Publication of AR084848A1 publication Critical patent/AR084848A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65746—Esters of oxyacids of phosphorus the molecule containing more than one cyclic phosphorus atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente se relaciona con un proceso para la purificación de 6,6’-[3,3’-di-tert-butil-5,5’-dimetoxi-1,1’-bifenil-2,2’-diil)bis(oxi)]bis(dibenzo[d,f][1,3,2]dioxafosfepina), abreviada biphephos de fórmula (1).Reivindicación 1: Un proceso para la purificación de 6,6’-[(3,3’-di-tert-butil-5,5’-dimetoxi-1,1’-bifenil-2,2’-diil)bis(oxi)]bis(dibenzo[d,f][1,3,2]dioxafosfepina) (“biphephos”), caracterizado porque comprende lavar el biphephos con un solvente seleccionado entre el grupo que comprende acetato de etilo, anisol, orto-xileno, tolueno, acetona, 2-propanol y alcanos C5-10 o mezclas de los mismos o con una mezcla de solventes que comprende uno o más de estos solventes, y/o se recristaliza desde dicho solvente o mezcla de solventes.
ARP120100118A 2011-01-13 2012-01-13 Proceso para la purificacion de 6,6’-(3,3’-di-tert-butil-5,5’-dimetoxi-1,1’-bifenil-2,2’-diil)bis(oxi)]bis(dibenzo[d,f][1,3,2]dioxafosfepina) (biphephos) AR084848A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102011002640.1A DE102011002640B4 (de) 2011-01-13 2011-01-13 Verfahren zur Aufreinigung von Biphephos

Publications (1)

Publication Number Publication Date
AR084848A1 true AR084848A1 (es) 2013-06-26

Family

ID=45470540

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120100118A AR084848A1 (es) 2011-01-13 2012-01-13 Proceso para la purificacion de 6,6’-(3,3’-di-tert-butil-5,5’-dimetoxi-1,1’-bifenil-2,2’-diil)bis(oxi)]bis(dibenzo[d,f][1,3,2]dioxafosfepina) (biphephos)

Country Status (13)

Country Link
US (1) US20130317246A1 (es)
EP (1) EP2663572A1 (es)
JP (1) JP2014510029A (es)
KR (1) KR20140037027A (es)
CN (1) CN103370327A (es)
AR (1) AR084848A1 (es)
BR (1) BR112013017893A2 (es)
DE (1) DE102011002640B4 (es)
MX (1) MX2013007831A (es)
SG (1) SG191942A1 (es)
TW (1) TW201245218A (es)
WO (1) WO2012095255A1 (es)
ZA (1) ZA201305971B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011002639A1 (de) * 2011-01-13 2012-07-19 Evonik Oxeno Gmbh Verfahren zur Herstellung von Biphephos
US10227365B2 (en) * 2011-10-31 2019-03-12 Dow Technology Investments Llc Preventing solvent of crystallization in production of polyphosphite ligands
CN104053663B (zh) * 2011-12-30 2017-07-04 巴斯夫欧洲公司 提纯有机二亚磷酸酯化合物的方法
WO2013151666A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of biologics and proteins associated with human disease
JP2015516143A (ja) 2012-04-02 2015-06-08 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． ヒト疾患に関連するタンパク質の産生のための修飾ポリヌクレオチド
DE102013219512A1 (de) 2012-10-12 2014-04-17 Evonik Degussa Gmbh Gemisch aus verschiedenen unsymmetrischen Bisphosphiten und dessen Verwendung als Katalysatorgemisch in der Hydroformylierung
DE102013219506A1 (de) 2012-10-12 2014-04-17 Evonik Degussa Gmbh Unsymmetrisches Bisphosphit
CA2887107A1 (en) 2012-10-12 2014-04-17 Evonik Degussa Gmbh Mixture of various unsymmetric bisphosphites and use thereof as a catalyst mixture in hydroformylation
EP2971010B1 (en) 2013-03-14 2020-06-10 ModernaTX, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
US20160194368A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Circular polynucleotides
US20160194625A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Chimeric polynucleotides
DE102014201756A1 (de) 2014-01-31 2015-08-06 Evonik Degussa Gmbh Reinigung chlorverschmutzter Organophosphorverbindungen
DE102014202500A1 (de) 2014-02-12 2015-08-13 Evonik Degussa Gmbh Verfahren zur Reduzierung des Chlorgehalts von Organobisphosphiten
DE102014203960A1 (de) 2014-03-05 2015-09-10 Evonik Degussa Gmbh Verfahren zur Herstellung von Aldehyden aus Alkanen und Synthesegas
CN106414467A (zh) 2014-05-20 2017-02-15 赢创德固赛有限公司 使用二甲基氨基丁烷、三乙胺或三乙醇胺降低有机单亚磷酸酯的氯含量的方法
EP3029044B1 (de) 2014-12-04 2019-05-01 Evonik Degussa GmbH Bisphosphite die einen unsymmetrischen biaryl-zentral-baustein aufweisen
CN107690435A (zh) * 2015-06-19 2018-02-13 陶氏技术投资有限责任公司 结晶配体6，6’‑[[3，3’，5，5’‑四(1，1‑二甲基乙基)‑[1，1’‑联苯]‑2，2’‑二基]双(氧基)]双二苯并[d，f][1，3，2]‑二氧杂磷杂庚英(dioxaphosphepin)
EP3147291A1 (de) 2015-09-28 2017-03-29 Evonik Degussa GmbH Verfahren zur reduzierung des chlorgehalts von organotetraphosphiten
CN105541916A (zh) * 2015-10-29 2016-05-04 天津渤化永利化工股份有限公司 一种联非弗司配体的合成方法
EP3165529B1 (de) * 2015-11-09 2018-09-05 Evonik Degussa GmbH Verfahren zur reduzierung des chlorgehalts von bisphosphiten mit 2,4-dimethylphenyl-einheiten
EP3176174A1 (de) 2015-12-03 2017-06-07 Evonik Degussa GmbH Verfahren zur reduzierung des chlorgehalts von organotetraphosphiten
KR101939399B1 (ko) * 2016-03-23 2019-01-16 (주)이스웨이 스마트 단말을 이용한 출석 인증 장치
UA119282C2 (uk) 2017-09-29 2019-05-27 Олександр Юрійович Микитюк Спосіб очищення та знезараження промислових стоків
TWI874467B (zh) 2019-11-05 2025-03-01 美商陶氏科技投資有限公司 用於自ｃ６或更高碳數烯烴氫甲醯化製程之催化劑淨化流回收銠之方法
EP4091712B1 (de) 2021-05-18 2024-05-15 Evonik Oxeno GmbH & Co. KG Verfahren zur regenerierung eines katalysators für die hydroformylierung von olefinen in der gasphase
CN113845547A (zh) * 2021-10-29 2021-12-28 山东京博石油化工有限公司 一种Biphephos的结晶溶剂化物和非溶剂化结晶形式及其制备方法和应用
EP4180439A1 (de) 2021-11-15 2023-05-17 Evonik Operations GmbH Verfahren zur reduzierung des chlorgehalts von organobisphosphiten mittels schutzgasfritte
PL4198001T3 (pl) * 2021-12-17 2024-09-09 Evonik Oxeno Gmbh & Co. Kg Kompleks Pt-bifenyl-jod i kompleks Pt-bifenyl-brom
EP4484437A1 (de) 2023-06-27 2025-01-01 Evonik Oxeno GmbH & Co. KG Verfahren zur herstellung von diphosphiten
CN117534540A (zh) * 2023-11-14 2024-02-09 山东京博石油化工有限公司 一种轻汽油制备c12醇并联产c5烷烃、异戊烯和/或叔戊醇的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4380676A (en) 1980-02-29 1983-04-19 Ciba-Geigy Corporation Process for the production of 2,2'-dihydroxy-biphenyls
US4668651A (en) 1985-09-05 1987-05-26 Union Carbide Corporation Transition metal complex catalyzed processes
US5440067A (en) 1994-11-18 1995-08-08 E. I. Dupont De Nemours And Company Catalyzed gas phase isomerization of nonconjugated 2-alkyl-3-monoalkenenitriles
US5449807A (en) 1994-11-18 1995-09-12 E. I. Du Pont De Nemours And Company Catalyzed vapor phase hydrocyanation of diolefinic compounds
US5962744A (en) 1998-03-27 1999-10-05 The Research Foundation Of State University Of New York Process for hydrocarbonylations in supercritical carbon dioxide
DE10360771A1 (de) * 2003-12-23 2005-07-28 Oxeno Olefinchemie Gmbh Verfahren zur Herstellung von dreiwertigen Organophosphor-Verbindungen
CN1986055B (zh) 2006-12-22 2012-06-27 中国科学院上海有机化学研究所 一种丙烯氢甲酰化催化体系和方法
CN101684130B (zh) 2008-09-25 2013-05-01 上海焦化有限公司 一种亚磷酸酯的制备方法
DE102008043584A1 (de) 2008-11-07 2010-05-12 Evonik Oxeno Gmbh Verfahren zur Herstellung von 6-Chlorodibenzo(d,f) (1,3,2)-dioxaphosphepin

Also Published As

Publication number Publication date
TW201245218A (en) 2012-11-16
US20130317246A1 (en) 2013-11-28
SG191942A1 (en) 2013-08-30
MX2013007831A (es) 2013-09-26
BR112013017893A2 (pt) 2016-10-11
CN103370327A (zh) 2013-10-23
WO2012095255A1 (de) 2012-07-19
KR20140037027A (ko) 2014-03-26
ZA201305971B (en) 2014-04-30
DE102011002640A1 (de) 2012-07-19
DE102011002640B4 (de) 2021-10-07
EP2663572A1 (de) 2013-11-20
JP2014510029A (ja) 2014-04-24

Similar Documents

Publication Publication Date Title
AR084848A1 (es) Proceso para la purificacion de 6,6’-(3,3’-di-tert-butil-5,5’-dimetoxi-1,1’-bifenil-2,2’-diil)bis(oxi)]bis(dibenzo[d,f][1,3,2]dioxafosfepina) (biphephos)
MX2016012984A (es) Derivados indol para uso en medicina.
AR084847A1 (es) Proceso para producir 6,6’-(3,3’-di-tert-butil-5,5’-dimetoxi-1,1’-bifenil-2,2’-diil)bis(oxi)]bis(dibenzo[d,f][1,3,2]dioxafosfepina) (biphephos)
AR110056A2 (es) Modulación de receptores quimiosensoriales y ligandos relacionados con los mismos
JP2014208621A5 (ja) 発光素子、ディスプレイモジュール、照明モジュール、発光装置、表示装置、照明装置、及び電子機器
CO6700838A2 (es) Compuestos sustituidos de banzamida
AR085425A1 (es) Inhibidores de la glucosilceramida sintasa
AR098912A1 (es) Inhibidores de syk
MX356615B (es) Un proceso para la separacion y purificacion de sulfuro de sodio.
CR20200276A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamientos de la hepatitis b (divisional exp. 2015-0059)
CO6020004A1 (es) Piridazinonilos macrociclicos como inhibidores de serina proteasa de hepatitis c
AR070953A1 (es) Proceso para estabilizar monomeros con insaturaciones olefinicas y una composicion que contiene dicho monomero
ATE557004T1 (de) 1h-benzoägüindol- verbindungen und sie enthaltende organische lumineszenzvorrichtung
AR088622A1 (es) 18-METIL-6,7-METILEN-3-OXO-17-PREGN-4-EN-21,17b-CARBOLACTONA, PREPARADOS FARMACEUTICOS QUE CONTIENEN LOS COMPUESTOS MENCIONADOS Y SU USO EN LA TERAPIA DE LA ENDOMETRIOSIS
CO6150135A2 (es) Bencilaminas un proceso para su produccion y su uso como agentes antiinflamatorios
BR112012033690A2 (pt) sais de cálcio de compostos como agentes anti-inflamatórios, imunomodulares e antitroliferativos
ES2539787T3 (es) Procedimiento y dispositivo para la purificación de productos de nitración
PE20090045A1 (es) Docetaxel cristalino anhidro estable y metodo para la preparacion del mismo
CO6362013A2 (es) Derivados de rifamicina
CO6700138A1 (es) Procedimiento de preparación de sal de l-arginina de perindoprilo
EA201792064A1 (ru) Биоразлагаемые поверхностно-активные сахароамиды для повышения нефтеотдачи
PE20142060A1 (es) Procedimientos para recuperar extrayente de disolvente organico de emulsiones estabilizadas con solidos formadas en circuitos de extraccion con disolvente hidrometalurgicos
AR088909A1 (es) Compuestos de hidrocarburos aromaticos policiclicos que contienen un atomo de s o un grupo s(=o)₂ en su estructura basica
ES2634294T3 (es) Procedimiento para la preparación de 1,4-quinonametidas sustituidas
AR073773A1 (es) Metodo para producir decitabina protegida beta-enriquecida.

Legal Events

Date Code Title Description
FB Suspension of granting procedure